]>
IRCT20191031045289N1 IRCT 2020-02-26 Shahid Beheshti University of Medical Sciences Aspirin Effect in the Prevention of Preterm Labor in Patient with Previous Spontaneous Preterm Birth Aspirin Effect in the Prevention of Preterm Labor in Patient with Previous Spontaneous Preterm Birth 2019-12-22 anticipated 380 Complete https://irct.ir/trial/43978 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Pregnant mothers with inclusion criteria will be selected as available sample and then will be randomly divided into intervention and non-intervention groups using random number table. 3 Preterm Birth. Intervention 1: Intervention group: the intervention group will be given 80 mg daily aspirin tablets produced by Hakim Pharmaceutical Company. Routine prenatal visits will be made for this groups.Other measures indicated for the prevention of preterm labor in the patient will be performed (from 16 weeks of proletone weekly to 36 weeks, and cerclage if CL> 25). Intervention 2: Control group: the control group will not be given aspirin. Routine prenatal visits will be made for this groups. Other measures indicated for the prevention of preterm labor in the patient will be performed (from 16 weeks of proletone weekly to 36 weeks, and cerclage if CL> 25). Yes - There is a plan to make this available What will be shared: All participants' information and study results will be shared after anonymity. When: After printing the results To whom: It will be available to everyone. Conditions: Use of the data is permitted by citing the source. Where to obtain: Dr. Zahra Dehghani z.dehghani1367@yahoo.com How to obtain: Contact Dr. Dehghani via the email address provided. Comments:
public Zahra Dehghani
No. 115, Teimourifar Ave., Emamat St., Tehran
Tehran Iran (Islamic Republic of) 1743674181 +98 21 7748 0345 n.ghaemi.983@gmail.com Shahid Beheshti University of Medical Sciences scientific Zahra Dehghani
No. 115, Teimourifar Ave., Emamat St., Tehran
Tehran Iran (Islamic Republic of) 1743674181 +98 21 7748 0345 n.ghaemi.983@gmail.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Singleton pregnancy Gestational age 8-16 weeks Maternal age upper than 18 years old Previous spontaneous preterm birth 18 years no limit Female History of preterm labor due to maternal cause Have other indications of aspirin use Thrombocytopenia Embryonic malformations in this pregnancy or previous preterm pregnancy O60 Preterm labor Treatment - Drugs N/A Intervention group: the intervention group will be given 80 mg daily aspirin tablets produced by Hakim Pharmaceutical Company. Routine prenatal visits will be made for this groups.Other measures indicated for the prevention of preterm labor in the patient will be performed (from 16 weeks of proletone weekly to 36 weeks, and cerclage if CL> 25). Control group: the control group will not be given aspirin. Routine prenatal visits will be made for this groups. Other measures indicated for the prevention of preterm labor in the patient will be performed (from 16 weeks of proletone weekly to 36 weeks, and cerclage if CL> 25). Preterm Labor. Timepoint: Pregnancy termination time. Method of measurement: Gestational age at delivery time. Shahid Beheshti University of Medical Sciences Approved 2019-12-08 Ethics committee of Shahid Beheshti University of Medical Sciences No. 115, Teymourifar Ave., Emamat St. Tehran Tehran Iran (Islamic Republic of)